Homefremanezumab

  • Teva Announces AJOVY™ (fremanezumab) approval in the US market

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva discontinues Chronic Cluster Headache trial for Fremanezumab

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Confirms September PDUFA Date for Fremanezumab

    • May 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Announces Publication of Ph III Data of Fremanezumab for the Preventive Treatment of Episodic Migraine

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva to Present New Data Across Multiple NS Therapeutic Areas at AAN

    • April 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Migraine CGRP drugs assessed for Clinical effectiveness & Economic impacts by recent ICER report

    • April 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • CRLs, leading to fremanezumab launch delay in Migraine, acknowledged by Celltrion

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more